Niagen Bioscience (NAGE) Invested Capital (2015 - 2019)

Niagen Bioscience (NAGE) has reported Invested Capital for 6 consecutive years, with $161000.0 the latest figure, recorded in Q2 2020.

• In Q2 2020, Invested Capital changed N/A year-over-year to $161000.0; the TTM figure through Mar 2021 stood at $161000.0 (changed N/A YoY), while the FY2018 annual figure was $871000.0, changed 0.0% from the prior year.
• Invested Capital fell to $161000.0 in Q2 2020 per NAGE's latest filing, from $871000.0 in the prior quarter.
• Across five years, Invested Capital topped out at $1.5 million in Q1 2016 and bottomed at $161000.0 in Q2 2020.
• Historically, Invested Capital has averaged $755115.6 across 4 years, with a median of $871000.0 in 2017.
• Annual changes were most pronounced in 2016 — Invested Capital slumped 77.5% — and 2017, when it surged 153.2%.
• Niagen Bioscience's Invested Capital stood at $344000.0 in 2016, then soared by 153.2% to $871000.0 in 2017, then changed by 0.0% to $871000.0 in 2018, then plunged by 81.52% to $161000.0 in 2020.
• Business Quant data shows NAGE's Invested Capital at $161000.0 in Q2 2020, $871000.0 in Q4 2018, and $871000.0 in Q4 2017.